Neeter, L. M. F. H.
Houben, I. P. L.
Nelemans, P. J.
Van Nijnatten, T. J. A.
Pijnappel, R. M.
Frotscher, C.
Osinga-de Jong, M.
Sanders, F.
Van Dalen, T.
Raat, H. P. J.
Essers, B. A. B.
Wildberger, J. E.
Smidt, M. L.
Lobbes, M. B. I. http://orcid.org/0000-0002-2103-6956
Funding for this research was provided by:
ZonMw (843001801)
GE Healthcare
Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+
Article History
Received: 20 June 2019
Accepted: 30 October 2019
First Online: 23 December 2019
Ethics approval and consent to participate
: The study protocol was approved by the Medical Ethics Review Committee of Maastricht University Medical Center+ in January 2018. Amendments are first submitted to this committee before implementation in the participating centers and communication to relevant parties. Before participants undergo any study activity, including randomization, informed consent must be signed. The Dutch informed consent form is provided as Additional file InternalRef removed.
: Not applicable.
: ML receives grant support by Bayer and GE Healthcare. He has also received several speaker fees from GE Healthcare. JW receives institutional support from Agfa, Bard, Bayer, GE Healthcare, Optimed, Philips, and Siemens. He is also a speaker for Bayer and Siemens. All the other authors declare that they have no competing interests.